[Facioscapulohumeral muscular dystrophy].
Nakagawa
M
M
Third Department of Internal Medicine, Kagoshima University Faculty of Medicine.
Higuchi
I
I
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000420:Albuterol / Q000627:therapeutic use; D002894:Chromosomes, Human, Pair 4 / Q000235:genetics; D015252:Deoxyribonucleases, Type II Site-Specific / Q000235:genetics; D003937:Diagnosis, Differential; D006801:Humans; D020391:Muscular Dystrophy, Facioscapulohumeral / Q000235:genetics / Q000503:physiopathology; D011379:Prognosis; D012091:Repetitive Sequences, Nucleic Acid / Q000235:genetics; D017384:Sequence Deletion
D000318:Adrenergic beta-Agonists; D015252:Deoxyribonucleases, Type II Site-Specific; C029312:GGTACC-specific type II deoxyribonucleases; D000420:Albuterol